DNA-binding protein RFX6
DNA-binding protein RFX6 (414-431) is a synthetic peptide fragment corresponding to amino acids 414 through 431 of the regulatory factor X6 (RFX6) protein. As a member of the RFX family, RFX6 is a transcription factor known for its crucial role in gene regulation, particularly in the context of pancreatic development and function. The 414-431 region of RFX6 encompasses a segment implicated in DNA binding and protein-protein interactions, making it a valuable tool for dissecting the molecular mechanisms underlying transcriptional control. Researchers leverage this peptide to investigate the functional domains of RFX6, explore its interaction networks, and study its contribution to transcriptional regulation in various cellular contexts.
Transcription factor domain mapping: The RFX6 (414-431) peptide is widely used in studies aimed at mapping the DNA-binding domains of the RFX6 transcription factor. By employing this synthetic fragment in binding assays, researchers can delineate the specific amino acid residues responsible for direct interaction with target DNA sequences. Such mapping is essential for understanding the structural basis of RFX6-mediated transcriptional regulation and can inform the design of mutagenesis experiments to further probe structure-function relationships.
Protein-protein interaction studies: The peptide serves as a targeted probe for investigating protein-protein interactions involving the C-terminal region of RFX6. Through techniques such as pull-down assays or surface plasmon resonance, the 414-431 fragment enables the identification of binding partners that associate with this domain, shedding light on the regulatory complexes that modulate RFX6 activity. Insights gained from these studies contribute to a deeper understanding of the molecular machinery governing gene expression in developmental and metabolic pathways.
Antibody generation and epitope mapping: Researchers utilize the RFX6 (414-431) peptide as an immunogen to generate domain-specific antibodies. These antibodies are instrumental in detecting endogenous RFX6 in various assay formats, including Western blotting, immunoprecipitation, and immunofluorescence. Furthermore, the peptide is employed in epitope mapping studies to characterize antibody specificity and binding affinity, which is critical for the development of reliable research reagents targeting RFX6.
Peptide-based inhibitor design: The defined sequence of the 414-431 region provides a template for designing peptide-based inhibitors that can modulate RFX6 function. By mimicking the native interaction motifs, such inhibitors can competitively block DNA binding or disrupt key protein-protein interactions, offering a strategic approach to dissecting RFX6-mediated regulatory pathways in vitro. These studies facilitate the exploration of RFX6 as a potential modulatory node in transcriptional networks.
Structural and biophysical analysis: The synthetic peptide is also employed in biophysical investigations aimed at elucidating the conformational properties of the RFX6 DNA-binding domain. Techniques such as circular dichroism spectroscopy, nuclear magnetic resonance, and crystallography benefit from the use of well-defined peptide fragments, enabling high-resolution analysis of secondary structure elements and interaction surfaces. Such structural insights are fundamental for advancing our molecular understanding of transcription factor dynamics and their regulatory roles in gene expression.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More